Log in
Enquire now
‌

US Patent 9920011 Enhanced erythropoiesis and iron metabolism

Patent 9920011 was granted and assigned to Fibrogen, Inc. on March, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Fibrogen, Inc.
Fibrogen, Inc.
Current Assignee
Fibrogen, Inc.
Fibrogen, Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9920011
Date of Patent
March 20, 2018
Patent Application Number
14084443
Date Filed
November 19, 2013
Patent Citations Received
‌
US Patent 12071443 Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereof
0
‌
US Patent 11780854 Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereof
Patent Primary Examiner
‌
Elizabeth C. Kemmerer
Patent abstract

The present invention relates to methods and compounds for regulating or enhancing erythropoiesis and iron metabolism, and for treating or preventing iron deficiency and anemia of chronic disease.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9920011 Enhanced erythropoiesis and iron metabolism

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us